MedTrace Logo

Clinical Relevance of Typing HLA-DR7-DQ2

NCT01813383 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 92

Last updated 2013-03-19

No results posted yet for this study

Summary

Celiac disease patients with HLA-DR7-DQ2 haplotype have the same histological, analytical and clinical behaviour as patients with HLA-DR3-DQ2 haplotype.

Conditions

  • Celiac Disease Patients Following Recommendations of ESPGHAN
  • HLA-DQ2 Typing Include HLA-DR7-DQ2 Haplotypes

Interventions

OTHER

There is not any intervention

Sponsors & Collaborators

  • Corporacion Parc Tauli

    lead OTHER

Principal Investigators

  • Juan Francisco Delgado de la Poza · Immunology Section, Laboratori. UDIAT-CD. Corporació Sanitària i Universitària Parc Taulí

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2012-12-31
Completion
2013-03-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01813383 on ClinicalTrials.gov